These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35738905)

  • 1.
    Le TM; Lee HR; Abt ER; Rashid K; Creech AL; Liang K; Cui J; Cho A; Wei L; Labora A; Chan C; Sanchez E; Kriti K; Karin D; Li L; Wu N; Mona C; Carlucci G; Hugo W; Wu TT; Donahue TR; Czernin J; Radu CG
    J Nucl Med; 2023 Jan; 64(1):117-123. PubMed ID: 35738905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

  • 3. Toll like receptor mediated immune stimulation can be visualized in vivo by [
    Pektor S; Bausbacher N; Otto G; Lawaczeck L; Grabbe S; Schreckenberger M; Miederer M
    Nucl Med Biol; 2016 Nov; 43(11):651-660. PubMed ID: 27552488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [
    Liang K; Abt ER; Le TM; Cho A; Dann AM; Cui J; Li L; Rashid K; Creech AL; Wei L; Ghukasyan R; Rosser EW; Wu N; Carlucci G; Czernin J; Donahue TR; Radu CG
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis.
    Ye Z; Lu X; Zhu M; Bi L; Yang F; Zhou B; Xu D; Yao L
    Mol Pharm; 2024 Jun; 21(6):2865-2877. PubMed ID: 38666508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
    Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
    Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
    Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
    J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of [
    Victorio CBL; Ong J; Tham JY; Reolo MJ; Novera W; Msallam R; Watanabe S; Kalimuddin S; Low JG; Vasudevan SG; Chacko AM
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4516-4528. PubMed ID: 35876869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel
    Fang J; Feng L; Meng L; Wang X; Liu H; Huang L; Zhang D; Li J; Zhuang R; Guo Z; Zhang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):27-37. PubMed ID: 36066666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
    Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
    Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mitchell KG; Amini B; Wang Y; Carter BW; Godoy MCB; Parra ER; Behrens C; Villalobos P; Reuben A; Lee JJ; Weissferdt A; Moran CA; Fujimoto J; Sepesi B; Walsh GL; Vaporciyan AA; Hofstetter WL; William WN; Gibbons DL; Wang J; Hwu P; Swisher SG; Piwnica-Worms D; Kadara H; Wistuba II; Heymach JV; Peng W; Cascone T
    Cancer Immunol Immunother; 2020 Aug; 69(8):1519-1534. PubMed ID: 32300858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.
    Flores LG; Yeh HH; Soghomonyan S; Young D; Bankson J; Hu Q; Alauddin M; Huff V; Gelovani JG
    Mol Imaging Biol; 2013 Apr; 15(2):175-85. PubMed ID: 22875335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
    Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice.
    Mirbolooki MR; Upadhyay SK; Constantinescu CC; Pan ML; Mukherjee J
    Nucl Med Biol; 2014 Jan; 41(1):10-6. PubMed ID: 24090673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of activation induced [18]F-FDG uptake in Dendritic Cells.
    Pektor S; Lawaczeck L; Tenzer S; Bausbacher N; Hoffmann MA; Schreckenberger M; Miederer M
    Nuklearmedizin; 2021 Apr; 60(2):90-98. PubMed ID: 33327008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [
    Zhang HJ; Mitchell S; Fang YH; Tsai HM; Piao L; Ousta A; Leoni L; Chen CT; Sharp WW
    Neurocrit Care; 2021 Feb; 34(1):64-72. PubMed ID: 32358767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT monitoring of β3 agonist-stimulated brown adipocyte recruitment in white adipose tissue.
    Park JW; Jung KH; Lee JH; Quach CH; Moon SH; Cho YS; Lee KH
    J Nucl Med; 2015 Jan; 56(1):153-8. PubMed ID: 25525187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
    Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
    Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.